Tilray Brands Inc is a global leader in the cannabis industry, specializing in the cultivation, production, and distribution of a diverse range of cannabis products. The company operates across various segments, including medical and recreational cannabis, as well as hemp-derived wellness products. Tilray focuses on innovation and quality, offering a portfolio that encompasses various formats such as dried flower, oils, edibles, and beverages. In addition to its core cannabis business, Tilray is dedicated to advancing research, education, and consumer awareness within the rapidly evolving market, positioning itself as a key player in the development and expansion of cannabis-related offerings worldwide. Read More
Shares of cannabis company Tilray Brands (NASDAQ:TLRY)
jumped 4.9% in the afternoon session after the company announced the launch of its new Humble Seed Whole Wheat Protein Crackers, now available at Whole Foods Market. This move marked a notable expansion of the company's wellness product offerings into a major retail chain. The positive sentiment also followed other recent events. Earlier in the week, an analyst upgraded the stock to a "Buy" rating, and at the end of July, CEO Irwin D. Simon purchased 165,000 shares. This insider purchase signaled strong confidence in the company's direction.
As the marijuana market grows more competitive, some retailers are shifting how they present their products to customers. These changes, going beyond aesthetics, are helping boost sales and creating a more comfortable and engaging customer experience.
As the marijuana market grows more competitive, some retailers are shifting how they present their products to customers. These changes, going beyond aesthetics, are helping boost sales and creating a more comfortable and engaging customer experience.
Tilray stock plunged yesterday, July 29, following a brutal fiscal Q4 earnings report that reinforced concerns about Tilray’s strategic direction and financial health spooking investors. Other LPs dropped in sympathy.
Cannabis company Tilray Brands (NASDAQ:TLRY) missed Wall Street’s revenue expectations in Q2 CY2025, with sales falling 2.3% year on year to $224.5 million. Its GAAP loss of $1.30 per share was significantly below analysts’ consensus estimates.
What a brutal six months it’s been for Tilray. The stock has dropped 45.6% and now trades at $0.64, rattling many shareholders. This was partly driven by its softer quarterly results and may have investors wondering how to approach the situation.
